A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
30 Jul 2024
Historique:
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: aheadofprint

Résumé

The sensitivity of LC-MS in quantifying target proteins in plasma/tissues is significantly hindered by coeluted matrix interferences. While antibody-based immuno-enrichment effectively reduces interferences, developing and optimizing antibodies are often time-consuming and costly. Here, by leveraging the orthogonal separation capability of Field Asymmetric Ion Mobility Spectrometry (FAIMS), we developed a FAIMS/differential-compensation-voltage (FAIMS/dCV) method for antibody-free, robust, and ultrasensitive quantification of target proteins directly from plasma/tissue digests. By comparing the intensity-CV profiles of the target vs coeluted endogenous interferences, the FAIMS/dCV approach identifies the optimal CV for quantification of each target protein, thus maximizing the signal-to-noise ratio (S/N). Compared to quantification without FAIMS, this technique dramatically reduces endogenous interferences, showing a median improvement of the S/N by 14.8-fold for the quantification of 17 representative protein drugs and biomarkers in plasma or tissues and a 5.2-fold median increase in S/N over conventional FAIMS approach, which uses the peak CV of each target. We also discovered that the established CV parameters remain consistent over months and are matrix-independent, affirming the robustness of the developed FAIMS/dCV method and the transferability of the method across matrices. The developed method was successfully demonstrated in three applications: the quantification of monoclonal antibodies with subng/mL LOQ in plasma, an investigation of the time courses of evolocumab and its target PCSK9 in a preclinical setting, and a clinical investigation of low abundance obesity-related biomarkers. This innovative and easy-to-use method has extensive potential in clinical and pharmaceutical research, particularly where sensitive and high-throughput quantification of protein drugs and biomarkers is required.

Identifiants

pubmed: 39078725
doi: 10.1021/acs.analchem.4c01888
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Qingqing Shen (Q)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.

Jie Pu (J)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.
Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Summit, New Jersey 07901, United States.

Chao Xue (C)

Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, New York 14214, United States.

Ming Zhang (M)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.
New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States.

Yang Qu (Y)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.
New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States.

Shihan Huo (S)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.

Michael Belford (M)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Charles Maxey (C)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Neloni Wijeratne (N)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Claudia Martins (C)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Scott Peterman (S)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Wei-Jun Qian (WJ)

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.

Cornelia Boeser (C)

Thermo Fisher Scientific, San Jose, California 95134, United States.

Jun Qu (J)

The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.
New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States.

Classifications MeSH